BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 9232344)

  • 1. DNA ploidy pattern and tumor suppressor gene p53 expression in gallbladder carcinoma.
    Roa I; Villaseca M; Araya JC; Roa J; de Aretxabala X; Fuentealba P; Melo A
    Cancer Epidemiol Biomarkers Prev; 1997 Jul; 6(7):547-50. PubMed ID: 9232344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The value of p53 protein expression in gallbladder carcinoma: analysis of 60 cases.
    da Rocha AO; Coutinho LM; Scholl JG; Leboutte LD
    Hepatogastroenterology; 2004; 51(59):1310-4. PubMed ID: 15362740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor DNA content in gallbladder carcinoma.
    Sato Y; Tanaka J; Koyama K; van Gulik TM; Lygidakis NJ; van der Heyde MN
    Hepatogastroenterology; 1993 Aug; 40(4):375-9. PubMed ID: 8406309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoreactivity evaluation of mutant p53 gene product with DNA ploidy pattern in colorectal carcinoma.
    Nasif WA; El-Emshaty HM; Tabll A; Elmasry SA; Attallah AM; Gad Elhak NA
    Hepatogastroenterology; 2004; 51(58):1001-6. PubMed ID: 15239234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p53 protein expression and prognosis in gallbladder carcinoma and premalignant lesions.
    Ajiki T; Onoyama H; Yamamoto M; Asaka K; Fujimori T; Maeda S; Saitoh Y
    Hepatogastroenterology; 1996; 43(9):521-6. PubMed ID: 8799388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic alterations involved in the development of gallbladder carcinomas from Greek patients.
    Saetta A; Lazaris AC; Michalopoulos NV; Davaris PS
    Hepatogastroenterology; 2001; 48(41):1284-8. PubMed ID: 11677947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High frequency of p53 gene mutation in adenocarcinomas of the gallbladder.
    Fujii K; Yokozaki H; Yasui W; Kuniyasu H; Hirata M; Kajiyama G; Tahara E
    Cancer Epidemiol Biomarkers Prev; 1996 Jun; 5(6):461-6. PubMed ID: 8781743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [DNA content and survival in subserous gallbladder carcinoma].
    Roa I; de Aretxabala X; Fuentealba P; Cabrera ME; Araya JC; Roa J
    Rev Med Chil; 2004 Jul; 132(7):794-800. PubMed ID: 15379325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of BAT-26 as an indicator of microsatellite instability in gallbladder carcinomas.
    Saetta A; Koilakou SV; Michalopoulos NV; Davaris PS
    Hepatogastroenterology; 2003; 50(54):1799-802. PubMed ID: 14696408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [p53 and p27 gene expression in subserosal gallbladder carcinoma].
    Roa E I; Lantadilla H S; Ibacache S G; de Aretxabala U X
    Rev Med Chil; 2009 Aug; 137(8):1017-22. PubMed ID: 19915764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of genetic alterations associated with DNA diploidy, aneuploidy and multiploidy in gastric cancers.
    Sugai T; Habano W; Jiao YF; Suzuki M; Takagane A; Nakamura S
    Oncology; 2005; 68(4-6):548-57. PubMed ID: 16037688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA ploidy patterns in gallbladder adenocarcinoma.
    Yamamoto M; Oda N; Tahara E
    Jpn J Clin Oncol; 1990 Mar; 20(1):83-6. PubMed ID: 2319702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p53 expression and DNA ploidy pattern in Egyptian colorectal carcinoma.
    Zalata KR; Leech SH; Ming SC; Nasif WA; Nada NA; Mohamed IE; Atallah AM; Gad-el-Hak NA
    Hepatogastroenterology; 2002; 49(47):1225-9. PubMed ID: 12239910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The correlation between the expression of p53 protein and DNA ploidy in patients with gastric cancer that has invaded the serosa.
    Wang Z; Ikeguchi M; Maeta M; Kaibara N
    Anticancer Res; 1997; 17(5A):3701-5. PubMed ID: 9413227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical and genetic analysis of non-small cell and small cell gallbladder carcinoma and their precursor lesions.
    Parwani AV; Geradts J; Caspers E; Offerhaus GJ; Yeo CJ; Cameron JL; Klimstra DS; Maitra A; Hruban RH; Argani P
    Mod Pathol; 2003 Apr; 16(4):299-308. PubMed ID: 12692194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [DNA ploidy pattern and p53 overexpression in gastric cancer].
    Tomisaki S; Tatsuo O; Hisao O; Sakaguchi Y; Kusumoto T; Ohno S; Ichiyoshi Y; Maehara Y; Sugimachi K
    Gan To Kagaku Ryoho; 1995 Jun; 22 Suppl 2():115-7. PubMed ID: 7611772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [P53 gene mutation in gallbladder cancer].
    Roa I; Melo A; Roa J; Araya J; Villaseca M; de Aretxabala X
    Rev Med Chil; 2000 Mar; 128(3):251-8. PubMed ID: 10962865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [An early carcinoma of the gallbladder with atypical epithelium ( a report of a case with elevated p53 expression)].
    Yabar HA; Watanabe H
    Rev Gastroenterol Peru; 1994; 14(1):65-8. PubMed ID: 8018902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colon cancer: p53 expression and DNA ploidy. Their relation to proximal or distal tumor site.
    García-Hirschfeld García J; Blanes Berenguel A; Vicioso Recio L; Márquez Moreno A; Rubio Garrido J; Matilla Vicente A
    Rev Esp Enferm Dig; 1999 Jul; 91(7):481-8. PubMed ID: 10477366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuclear DNA content, an adjunct to p53 and Ki-67 as a marker of resistance to radiation therapy in oral cavity and pharyngeal squamous cell carcinoma.
    Raybaud H; Fortin A; Bairati I; Morency R; Monteil RA; Têtu B
    Int J Oral Maxillofac Surg; 2000 Feb; 29(1):36-41. PubMed ID: 10691142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.